MAIOLINO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.352
EU - Europa 475
AS - Asia 294
OC - Oceania 2
SA - Sud America 2
Totale 5.125
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.349
CN - Cina 228
IT - Italia 157
SE - Svezia 110
FI - Finlandia 63
GB - Regno Unito 47
DE - Germania 41
VN - Vietnam 35
UA - Ucraina 28
IN - India 21
IE - Irlanda 6
NL - Olanda 6
AT - Austria 3
FR - Francia 3
HK - Hong Kong 3
SG - Singapore 3
SI - Slovenia 3
BG - Bulgaria 2
CA - Canada 2
MY - Malesia 2
PE - Perù 2
RU - Federazione Russa 2
AU - Australia 1
DK - Danimarca 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
Totale 5.125
Salva come PNG Salva come JPEG
Città #
Fairfield 885
Woodbridge 454
Chandler 361
Houston 339
Ashburn 334
Seattle 317
Ann Arbor 296
Cambridge 268
Wilmington 266
Jacksonville 97
Princeton 81
San Diego 76
Padova 67
Medford 57
Roxbury 53
Beijing 52
Des Moines 44
Nanjing 37
Boardman 36
Dong Ket 35
Helsinki 34
New York 28
Jinan 19
Guangzhou 16
London 11
Hebei 10
Shenyang 9
Changsha 7
Jiaxing 7
Nanchang 7
Redwood City 7
Cagliari 6
Hangzhou 6
Milan 6
Dublin 5
Kunming 5
Lanzhou 5
Baotou 4
Norwalk 4
Rome 4
Shanghai 4
Huizen 3
Islington 3
Kharkiv 3
San Jose 3
Tianjin 3
Zhengzhou 3
Baiano 2
Bergamo 2
Brescia 2
Chongqing 2
Fuzhou 2
Hefei 2
Kuala Lumpur 2
Lima 2
Ogden 2
Orange 2
Paris 2
Prescot 2
Quzhou 2
Rockville 2
Sofia 2
Taizhou 2
Trento 2
Vienna 2
Villorba 2
Acton 1
Auckland 1
Belgrade 1
Borås 1
Bottanuco 1
Brendola 1
Bristol 1
Budapest 1
Buffalo 1
Böblingen 1
Cardiff 1
Castelfranco Veneto 1
Castelnuovo di Val di Cecina 1
Chiswick 1
Dearborn 1
Derry 1
Esslingen am Neckar 1
Falls Church 1
Frankfurt am Main 1
Gunzenhausen 1
Indiana 1
Irkutsk 1
Kherson 1
Kilburn 1
Kongens Lyngby 1
Las Vegas 1
Lishui 1
Los Angeles 1
Maastricht 1
Mahbubnagar 1
Miami Beach 1
Mountain View 1
Nagold 1
Nam-gu 1
Totale 4.449
Salva come PNG Salva come JPEG
Nome #
PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy 275
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 166
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. 139
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua) 136
Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy 129
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 128
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 120
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 113
Macrolides for KCNJ5–mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism 113
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women 110
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. 105
Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients 104
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term 104
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. 102
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design 100
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 95
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 92
A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma 92
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. 91
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 90
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 88
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives 87
Under treatment with lipid-lowering drugs of high-risk coronary heart disease patients of the GENICA study 86
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 86
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 86
Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects 85
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 84
Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives 82
Cure with cryoablation of arterial hypertension due to a renin-producing tumor. 82
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble 79
The T-786 C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in caucasian patients of the GENICA study 77
The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension. 74
To reconsider (limit) the use of phosphate based food and beverages additives. A real need for health preservation. 73
Atrial fibrillation as presenting sign of primary aldosteronism: Results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study 72
Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension 68
Is there an increased heme oxygenase-1 behind the antioxidant effects of green tea on blood pressure and sympathoexcitation reduction? 67
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 67
Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients 67
Oxidative stress in hypertension and cardiovascular-renal remodeling:focus on the renin-angiotensin-aldosterone system 64
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 63
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 63
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 62
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 62
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 59
New insights on the renal protective effects of mineralocorticoid receptor antagonists. 57
Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in KCNJ5 Mutated Adenoma Cells Ex Vivo 55
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 55
Magnesium, cardiovascular-renal disease and the Gitelman's syndrome paradox. 54
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 52
Recent advances in the diagnosis and management of obstructive sleep apnea 51
Adrenal Venous Sampling: Where Do We Stand? 51
Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines! 50
Primary aldosteronism in elderly, old, and very old patients 50
The cardiovascular consequences of hyperaldosteronism 46
-786C and G894T variants of the Endothelial Nitric Oxide Synthase Gene and training-induced correction of endothelial dysfunction in coronary artery disease patients. 45
Survival and rehospitalization in patients with severe ischemic mitral regurgitation and multivessel coronary artery disease undergoing different treatment 44
Comparative study at computed tomography angiography and intravascular ultrasound of coronary atherosclerotic plaques 42
Arterial Hypertension, Aldosterone, and Atrial Fibrillation 41
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 41
Moderate-to-severe ischeamic mitral regurgitation and multivessel coronary artery disease: impact of different treatment on survival and rehospitalization 38
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 36
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study 34
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 34
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 34
The Molecular Basis of the Interplay Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulation 31
Excess arterial damage in hyperaldosteronism: Further evidence from pressure wave analysis 30
Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure 29
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 19
International multicenter survey on screening and confirmatory testing in primary aldosteronism 6
Totale 5.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.473
article - articoli 16.892
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 226
Totale 34.591
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019383 0 0 0 0 0 0 0 0 0 63 169 151
2019/20201.233 122 52 24 130 141 78 151 128 168 99 90 50
2020/20211.185 44 70 43 87 33 40 87 86 120 300 99 176
2021/2022959 13 90 88 83 92 79 51 102 53 25 73 210
2022/2023708 142 82 26 81 104 84 6 52 86 13 25 7
2023/2024259 18 43 51 29 16 41 22 16 8 15 0 0
Totale 5.212